Home › Research › Prevention and risk
Hormonal and Metabolic Changes of Aging and the Influence of Lifestyle Modifications
Pataky MW, Young WF, Nair KS.. Mayo Clinic proceedings, 2021-03-01
Topic: Risk, prevention and care in population studies
Plain-language summary
Increased life expectancy combined with the aging baby boomer generation has resulted in an unprecedented global expansion of the elderly population. The growing population of older adults and increased rate of age-related chronic illness has caused a substantial socioeconomic burden. The gradual and progressive age-related decline in hormone production and action has a detrimental impact on human health by increasing risk for chronic disease and reducing life span. This article reviews the age-related decline in hormone production, as well as age-related biochemical and body composition changes that reduce the bioavailability and actions of some hormones. The impact of hormonal changes on various chronic conditions including frailty, diabetes, cardiovascular disease, and dementia are also discussed. Hormone replacement therapy has been attempted in many clinical trials to reverse and/or prevent the hormonal decline in aging to combat the progression of age-related diseases. Unfortunately, hormone replacement therapy is not a panacea, as it often results in various adverse events that outweigh its potential health benefits. Therefore, except in some specific individual cases, hormone replacement is not recommended. Rather, positive lifestyle modifications such as regular aerobic and resistance exercise programs and/or healthy calorically restricted diet can favorably affect endocrine and metabolic functions and act as countermeasures to various age-related diseases. We provide a critical review of the available data and offer recommendations that hopefully will form the groundwork for physicians/scientists to develop and optimize new endocrine-targeted therapies and lifestyle modifications that can better address age-related decline in heath.
What this study adds
Evidence grade: Low
This is a narrative review. This review describes how age-related hormonal decline is linked to chronic conditions including dementia, and states that hormone replacement therapy often causes adverse events that outweigh its benefits and is not recommended except in specific cases. It suggests positive lifestyle changes such as exercise and a healthy calorically restricted diet can favorably affect endocrine and body composition changes, but it does not show that any of these prevent Alzheimer's disease.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Pataky, M. W., Young, W. F., & Nair, K. S. (2021). Hormonal and Metabolic Changes of Aging and the Influence of Lifestyle Modifications. Mayo Clinic proceedings. https://doi.org/10.1016/j.mayocp.2020.07.033
Vancouver
Pataky MW, Young WF, Nair KS. Hormonal and Metabolic Changes of Aging and the Influence of Lifestyle Modifications. Mayo Clinic proceedings. 2021. doi:10.1016/j.mayocp.2020.07.033. PMID: 33673927.
BibTeX
@article{pataky2021-33673927,
author = {Pataky, M. W. and Young, W. F. and Nair, K. S.},
title = {{Hormonal and Metabolic Changes of Aging and the Influence of Lifestyle Modifications}},
journal = {Mayo Clinic proceedings},
year = {2021},
doi = {10.1016/j.mayocp.2020.07.033},
pmid = {33673927},
url = {https://doi.org/10.1016/j.mayocp.2020.07.033}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Unfortunately, hormone replacement therapy is not a panacea, as it often results in various adverse events that outweigh its potential health benefits.
Why it matters
This review describes how age-related hormonal decline is linked to chronic conditions including dementia, and states that hormone replacement therapy often causes adverse events that outweigh its benefits and is not recommended except in specific cases. It suggests positive lifestyle changes such as exercise and a healthy calorically restricted diet can favorably affect endocrine and body composition changes, but it does not show that any of these prevent Alzheimer's disease.
New to this subject? Start with our plain-English guide: Prevention →
Study details
- Evidence strengthLow
How this study scored 47/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Mayo Clinic proceedings) |
| Journal's citation record | 3 / 4 | Mayo Clinic Proceedings: journal h-index 293 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 3 / 5 | 2021 — within 6 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 5 / 7 | Cited 201 times (OpenAlex, 2026-10-10) |
| Citations per year | 4 / 5 | 28.7 citations a year over 7 year(s) since 2021 |
| Impact for its field and year | 4 / 6 | Cited 14.1× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 3 / 4 | Cited 153 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author K. Sreekumaran Nair: h-index 97 (OpenAlex, whole career) |
| Institution's track record | 2 / 3 | Mayo Clinic: institution h-index 1,606 (OpenAlex) |
| Multicenter collaboration | 0 / 3 | OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 33673927) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 47 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1016/j.mayocp.2020.07.033
- PubMed: 33673927
- Original source →
- Free full text: Mayo Clinic Proceedings →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Prevention and risk from nearby years
Also in Prevention and risk
265 studies in the library are filed under Prevention and risk with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Prevention and risk hub.